Connect with us
Information

WORLD EDITION
Australia
North America
World

Investing News NetworkYour trusted source for investing success

WORLD EDITION
North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

nyse:bmy

POPULAR ARTICLES

Bristol Myers Squibb Reports First Quarter Financial Results for 2023

life science investing

Bristol Myers Squibb Reports First Quarter Financial Results for 2023

Bristol Myers Squibb Announces Leadership Transition Plan

Bristol Myers Squibb Announces Leadership Transition Plan

Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for CAMZYOS® for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy

Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for CAMZYOS® for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy

LATEST ARTICLES

Bristol Myers Squibb Strengthens Cell Therapy Capabilities by Adding New U.S. Manufacturing Facility for Viral Vector Production

Bristol Myers Squibb Strengthens Cell Therapy Capabilities by Adding New U.S. Manufacturing Facility for Viral Vector Production

Pharma Market Update: H1 2021 in Review

pharmaceutical investing

Pharma Market Update: H1 2021 in Review

pharmaceutical investing

Bristol-Myers Squibb Reports Q4 and Full Year Results for 2019

Cannabis Firm Applies for Voluntary Delisting From the CSE

cannabis investing

Cannabis Firm Applies for Voluntary Delisting From the CSE

AbbVie to Acquire Allergan in Blockbuster US$63 Billion Deal

pharmaceutical investing

AbbVie to Acquire Allergan in Blockbuster US$63 Billion Deal

pharmaceutical investing

SELLAS Life Sciences Group and Cancer Center to Study Galinpepimut-S in Combination with Nivolumab in Patients with Malignant Pleural Mesothelioma

pharmaceutical investing

U.S. Food and Drug Administration Accepts for Priority Review Bristol-Myers Squibb’s Application for Empliciti (elotuzumab)

Bristol-Myers Squibb’s Opdivo (nivolumab) + Low-Dose Yervoy (ipilimumab) is the First Immuno-Oncology Combination Approved for MSI-H/dMMR mCRC Patients

European Commission Approves Expanded Indication for Sprycel (dasatinib)

pharmaceutical investing

Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Opdivo (nivolumab)

Latest News

Quimbaya Gold Announces Termination of LOI with Denarius Metals

Silver Crown Provides Corporate Update

Eric Sprott Announces Securities of Summa Silver Corp.

Silver47 and Summa Silver Complete Merger to Create a Premier U.S. High Grade Silver Explorer & Developer

Element79 Gold Corp Announces Execution of Definitive Agreement to Acquire Gold Mountain Project in Nevada

Outlook Reports

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

North Shore Uranium

NSU:CC

Skyharbour Resources

SYH:CA

Westport Fuel Systems

WPRT

Piche Resources

PR2:AU

Quimbaya Gold

QIM:CC

Sranan Gold

SRAN:CC

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES